NYSE: ENOV | Industrials / Industrial Products / USA |
51.65 | -0.2300 | -0.44% | Vol 234.11K | 1Y Perf 5.30% |
Sep 22nd, 2023 16:00 DELAYED |
BID | 47.16 | ASK | 54.11 | ||
Open | 51.88 | Previous Close | 51.88 | ||
Pre-Market | - | After-Market | 51.65 | ||
- - | - -% |
Target Price | 78.50 | Analyst Rating | Strong Buy 1.20 | |
Potential % | 51.98 | Finscreener Ranking | — - | |
Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | ★★ 46.12 | |
Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | ★★ 45.65 | |
Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
Price Range Ratio 52W % | 34.03 | Earnings Rating | — | |
Market Cap | 2.82B | Earnings Date | 1st Nov 2023 | |
Alpha | -0.01 | Standard Deviation | 0.12 | |
Beta | 1.56 |
Today's Price Range 51.5152.29 | 52W Range 43.8866.71 | 5 Year PE Ratio Range -1.80101.10 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -3.00% | ||
1 Month | -7.39% | ||
3 Months | -13.72% | ||
6 Months | 4.34% | ||
1 Year | 5.30% | ||
3 Years | -122.34% | ||
5 Years | -118.48% | ||
10 Years | -111.92% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | -2.36 | |||
ROE last 12 Months | 0.59 | |||
ROA (5Y Avg) | -1.00 | |||
ROA last 12 Months | 0.38 | |||
ROC (5Y Avg) | 0.35 | |||
ROC last 12 Months | 1.47 | |||
Return on invested Capital Q | -1.54 | |||
Return on invested Capital Y | 0.14 | |||
Assets Turnover | 0.10 | |||
Receivables Turnover | 0.90 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
153.00 | ||||
0.92 | ||||
2.74 | ||||
41.90 | ||||
-19.40 | ||||
2.60 | ||||
9.53 | ||||
29.63 | ||||
3.42B | ||||
Forward PE | - | |||
PEG | - |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.60 | ||||
1.20 | ||||
0.02 | ||||
0.15 | ||||
4.90 | ||||
Leverage Ratio | 1.50 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
42.20 | ||||
8.30 | ||||
14.20 | ||||
2.40 | ||||
2.32 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
1.15B | ||||
21.32 | ||||
0.44 | ||||
0.30 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
- | ||||
- | ||||
- | ||||
- | ||||
Payout ratio | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q02 2023 | 0.53 | 0.61 | 15.09 |
Q01 2023 | 0.37 | 0.44 | 18.92 |
Q04 2022 | 0.69 | 0.72 | 4.35 |
Q03 2022 | 0.47 | 0.59 | 25.53 |
Q02 2022 | 0.49 | 0.59 | 20.41 |
Q01 2022 | 0.34 | 0.37 | 8.82 |
Q04 2021 | 1.71 | 1.77 | 3.51 |
Q03 2021 | 1.62 | 1.62 | 0.00 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
- | - | - | - |
- | - | - | - |
- | - | - | - |
- | - | - | - |
Next Report Date | 1st Nov 2023 |
Estimated EPS Next Report | 0.52 |
Estimates Count | 1 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 234.11K |
Shares Outstanding | 54.54K |
Shares Float | 49.68M |
Trades Count | 5.24K |
Dollar Volume | 12.12M |
Avg. Volume | 340.78K |
Avg. Weekly Volume | 369.11K |
Avg. Monthly Volume | 318.02K |
Avg. Quarterly Volume | 335.21K |
Enovis Corporation (NYSE: ENOV) stock closed at 51.65 per share at the end of the most recent trading day (a -0.44% change compared to the prior day closing price) with a volume of 234.11K shares and market capitalization of 2.82B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Industrial Products industry, Industrials sector and employs 16200 people. Enovis Corporation CEO is Matthew L. Trerotola.
The one-year performance of Enovis Corporation stock is 5.3%, while year-to-date (YTD) performance is -3.49%. ENOV stock has a five-year performance of -118.48%. Its 52-week range is between 43.88 and 66.71, which gives ENOV stock a 52-week price range ratio of 34.03%
Enovis Corporation currently has a PE ratio of 153.00, a price-to-book (PB) ratio of 0.92, a price-to-sale (PS) ratio of 2.74, a price to cashflow ratio of 41.90, a PEG ratio of -, a ROA of 0.38%, a ROC of 1.47% and a ROE of 0.59%. The company’s profit margin is 2.32%, its EBITDA margin is 14.20%, and its revenue ttm is $1.15 Billion , which makes it $21.32 revenue per share.
Of the last four earnings reports from Enovis Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.52 for the next earnings report. Enovis Corporation’s next earnings report date is 01st Nov 2023.
The consensus rating of Wall Street analysts for Enovis Corporation is Strong Buy (1.2), with a target price of $78.5, which is +51.98% compared to the current price. The earnings rating for Enovis Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Enovis Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Enovis Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 43.46, ATR14 : 1.15, CCI20 : -157.29, Chaikin Money Flow : -0.29, MACD : -1.38, Money Flow Index : 14.95, ROC : -5.45, RSI : 29.96, STOCH (14,3) : 2.92, STOCH RSI : 0.00, UO : 29.02, Williams %R : -97.08), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Enovis Corporation in the last 12-months were: Brady Shirley (Sold 13 675 shares of value $775 630 ), Daniel Pryor (Sold 9 833 shares of value $559 523 ), John Kleckner (Sold 134 shares of value $8 234 ), Lang Patricia (Sold 3 693 shares of value $210 962 ), Matthew Trerotola (Sold 33 385 shares of value $1 902 579 ), Perfall A. (Option Excercise at a value of $118 507), Perfall A. (Sold 2 793 shares of value $145 599 ), Tandy Bradley (Sold 4 807 shares of value $274 200 ), Vinnakota Rajiv (Option Excercise at a value of $59 232), Vinnakota Rajiv (Sold 1 396 shares of value $79 823 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Strong Buy | Strong Buy | Strong Buy |
Colfax is a diversified technology firm that produces welding equipment and medical devices. Following the sale of its air and gas handling business in 2019, Colfax's remaining portfolio is organized into two segments: fabrication technology and medical technology. Fabrication technology is a leading manufacturer of equipment and consumables used in welding, cutting, and joining applications, mostly marketed under the ESAB brand name. The medical technology segment makes medical devices, including orthopedic braces, reconstructive implants, and other products used for rehabilitation, physical therapy, and pain management. The company generated roughly $3.9 billion in revenue in 2021.
CEO: Matthew L. Trerotola
Telephone: +1 302 252-9160
Address: 420 National Business Parkway, Annapolis Junction 20701, MD, US
Number of employees: 16 200
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.